Donald Notman | Chief Financial Officer |
Antony Mattessich | President and Chief Executive Officer |
Dr. Michael Goldstein | President-Ophthalmology and Chief Medical Officer |
Scott Corning | Senior Vice President, Commercial |
Chris White | Senior Vice President, Business and Corporate Development |
Jon Wolleben | JMP Securities |
Joe Catanzaro | Piper Sandler |
Georgi Yordanov | Cowen and Company |
Yi Chen | H.C. Wainwright |
Anita Dushyanth | Berenberg |
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix Second Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. It is now my pleasure to turn the call over to Donald Notman, Chief Financial Officer of Ocular Therapeutix.